258 related articles for article (PubMed ID: 34375173)
21. HSPB1 as a novel regulator of ferroptotic cancer cell death.
Sun X; Ou Z; Xie M; Kang R; Fan Y; Niu X; Wang H; Cao L; Tang D
Oncogene; 2015 Nov; 34(45):5617-25. PubMed ID: 25728673
[TBL] [Abstract][Full Text] [Related]
22. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
Cheng Q; Bao L; Li M; Chang K; Yi X
J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation.
Jin X; Tang J; Qiu X; Nie X; Ou S; Wu G; Zhang R; Zhu J
Cell Death Discov; 2024 Jan; 10(1):45. PubMed ID: 38267442
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy.
Xie S; Sun W; Zhang C; Dong B; Yang J; Hou M; Xiong L; Cai B; Liu X; Xue W
ACS Nano; 2021 Apr; 15(4):7179-7194. PubMed ID: 33861924
[TBL] [Abstract][Full Text] [Related]
25. Ferroptosis-driven nanotherapeutics for cancer treatment.
Shan X; Li S; Sun B; Chen Q; Sun J; He Z; Luo C
J Control Release; 2020 Mar; 319():322-332. PubMed ID: 31917296
[TBL] [Abstract][Full Text] [Related]
26. Biological protein mediated ferroptotic tumor nanotherapeutics.
Tao J; Li C; Zheng Y; Wang F; Zhang M; Wu X; Chen Y; Zeng Q; Chen F; Fei W
J Mater Chem B; 2021 Nov; 9(45):9262-9284. PubMed ID: 34730601
[TBL] [Abstract][Full Text] [Related]
27. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
28. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer.
Qi X; Wan Z; Jiang B; Ouyang Y; Feng W; Zhu H; Tan Y; He R; Xie L; Li Y
Front Immunol; 2022; 13():1038225. PubMed ID: 36505465
[TBL] [Abstract][Full Text] [Related]
29. Metadherin enhances vulnerability of cancer cells to ferroptosis.
Bi J; Yang S; Li L; Dai Q; Borcherding N; Wagner BA; Buettner GR; Spitz DR; Leslie KK; Zhang J; Meng X
Cell Death Dis; 2019 Sep; 10(10):682. PubMed ID: 31527591
[TBL] [Abstract][Full Text] [Related]
30. The mechanisms and therapeutic targets of ferroptosis in cancer.
Ye L; Jin F; Kumar SK; Dai Y
Expert Opin Ther Targets; 2021 Nov; 25(11):965-986. PubMed ID: 34821176
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?
Zhou Q; Tao C; Yuan J; Pan F; Wang R
Biomed Pharmacother; 2023 Sep; 165():115251. PubMed ID: 37523985
[TBL] [Abstract][Full Text] [Related]
32. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?
Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R
Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962
[TBL] [Abstract][Full Text] [Related]
33. Overview of Ferroptosis and Synthetic Lethality Strategies.
Kinowaki Y; Taguchi T; Onishi I; Kirimura S; Kitagawa M; Yamamoto K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502181
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
Lee J; You JH; Shin D; Roh JL
Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
[No Abstract] [Full Text] [Related]
35. Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death.
Tesfay L; Paul BT; Konstorum A; Deng Z; Cox AO; Lee J; Furdui CM; Hegde P; Torti FM; Torti SV
Cancer Res; 2019 Oct; 79(20):5355-5366. PubMed ID: 31270077
[TBL] [Abstract][Full Text] [Related]
36. Ferroptotic Cell Death: New Regulatory Mechanisms for Metabolic Diseases.
Le Y; Zhang Z; Wang C; Lu D
Endocr Metab Immune Disord Drug Targets; 2021; 21(5):785-800. PubMed ID: 32735532
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial transfer in PC-3 cells fingerprinted in ferroptosis sensitivity: a brand new approach targeting cancer metabolism.
Nikoo A; Roudkenar MH; Sato T; Kuwahara Y; Tomita K; Pourmohammadi-Bejarpasi Z; Najafi-Ghalehlou N; Roushandeh AM
Hum Cell; 2023 Jul; 36(4):1441-1450. PubMed ID: 36961656
[TBL] [Abstract][Full Text] [Related]
38. The ferroptosis inducer erastin irreversibly inhibits system x
Sato M; Kusumi R; Hamashima S; Kobayashi S; Sasaki S; Komiyama Y; Izumikawa T; Conrad M; Bannai S; Sato H
Sci Rep; 2018 Jan; 8(1):968. PubMed ID: 29343855
[TBL] [Abstract][Full Text] [Related]
39. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
40. Redox Modulation and Induction of Ferroptosis as a New Therapeutic Strategy in Hepatocellular Carcinoma.
Lippmann J; Petri K; Fulda S; Liese J
Transl Oncol; 2020 Aug; 13(8):100785. PubMed ID: 32416440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
